Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Greco

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Urban Health : Bulletin of the New York Academy of Medicine|September 23, 2020
Global Climate Implications for Homelessness: A Scoping ReviewSean A Kidd, Susan Greco, Kwame McKenzie
Foodborne Pathogens and Disease|December 5, 2018
Estimated Annual Deaths, Hospitalizations, and Emergency Department and Physician Office Visits from Foodborne Illness in OntarioChristopher Drudge, Susan Greco, JinHee Kim, et al.
Diabetes Research and Clinical Practice|January 24, 2004
Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazoneLois Jovanovic, David R Hassman, Brent Gooch, et al.
Diabetes Care|May 27, 2004
Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone armMohammed F Saad, Susan Greco, Kwame Osei, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Urban Health : Bulletin of the New York Academy of Medicine|September 23, 2020
Global Climate Implications for Homelessness: A Scoping ReviewSean A Kidd, Susan Greco, Kwame McKenzie
Foodborne Pathogens and Disease|December 5, 2018
Estimated Annual Deaths, Hospitalizations, and Emergency Department and Physician Office Visits from Foodborne Illness in OntarioChristopher Drudge, Susan Greco, JinHee Kim, et al.
Diabetes Research and Clinical Practice|January 24, 2004
Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazoneLois Jovanovic, David R Hassman, Brent Gooch, et al.
Diabetes Care|May 27, 2004
Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone armMohammed F Saad, Susan Greco, Kwame Osei, et al.
Pageof 1